SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 161 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $776,000 | +23.0% | 92,322 | +76.5% | 1.17% | +7.7% |
| Q2 2017 | $631,000 | +188.1% | 52,293 | +133.7% | 1.09% | +277.1% |
| Q1 2017 | $219,000 | -73.8% | 22,376 | -83.5% | 0.29% | -70.0% |
| Q4 2016 | $837,000 | -79.7% | 135,274 | -58.7% | 0.96% | -70.6% |
| Q3 2016 | $4,129,000 | +75.7% | 327,825 | +64.4% | 3.27% | +62.2% |
| Q2 2016 | $2,350,000 | +434.1% | 199,408 | +56.2% | 2.02% | +337.7% |
| Q1 2016 | $440,000 | -88.7% | 127,700 | -76.6% | 0.46% | -83.9% |
| Q4 2015 | $3,888,000 | – | 544,800 | – | 2.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |